These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 29113730)

  • 1. Conversion to Resection in Patients Receiving Systemic Chemotherapy for Unresectable and/or Metastatic Colorectal Cancer-Predictive Factors and Prognosis.
    Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Kaneko M; Murono K
    Clin Colorectal Cancer; 2018 Mar; 17(1):e91-e97. PubMed ID: 29113730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience.
    Moretto R; Germani MM; Borelli B; Conca V; Rossini D; Boraschi P; Donati F; Urbani L; Lonardi S; Bergamo F; Cerma K; Ramondo G; D'Amico FE; Salvatore L; Valente G; Barbaro B; Giuliante F; Di Maio M; Masi G; Cremolini C
    ESMO Open; 2024 Apr; 9(4):102991. PubMed ID: 38631269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and predictive factors of conversion surgery for initially unresectable advanced colorectal cancer.
    Ohira G; Endo S; Imanishi S; Tochigi T; Maruyama T; Hayano K; Maruyama M; Matsubara H
    Langenbecks Arch Surg; 2024 Jun; 409(1):182. PubMed ID: 38860986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the effectiveness of targeted agents in adjuvant therapy for patients with metastatic colorectal cancer undergoing surgical resection: a retrospective cohort study.
    Su YC; Wu CC; Chen YH; Su CC; Chang YC; Hsieh MC; Kao Yang YH
    Ther Adv Med Oncol; 2024; 16():17588359241246427. PubMed ID: 38655393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy for Unresectable Advanced, Metastatic or Recurrent Colorectal Cancer].
    Miyashita Y; Kawazoe A; Yoshino T
    Gan To Kagaku Ryoho; 2024 Mar; 51(3):245-249. PubMed ID: 38494801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient preference and decision-making for initiating metastatic colorectal cancer medical treatment.
    Fu AZ; Graves KD; Jensen RE; Marshall JL; Formoso M; Potosky AL
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):699-706. PubMed ID: 26577827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic colorectal cancer-past, progress and future.
    Field K; Lipton L
    World J Gastroenterol; 2007 Jul; 13(28):3806-15. PubMed ID: 17657834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal Treatment of Metastatic Rectal Cancer in a Young Patient: Case Report and Literature Review.
    Popescu I; Dudău AM; Dima S; Herlea V; Croitoru VM; Dinu IM; Miron M; Lupescu I; Croitoru-Cazacu IM; Dumitru R; Croitoru AE
    Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenic agents in metastatic colorectal cancer.
    Konda B; Shum H; Rajdev L
    World J Gastrointest Oncol; 2015 Jul; 7(7):71-86. PubMed ID: 26191351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Impact of Nutrition and Inflammation Assessment Tools in Colorectal Cancer Treatment.
    Aoyama T; Yukawa N; Saito A
    Anticancer Res; 2024 Apr; 44(4):1335-1351. PubMed ID: 38537954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Standard Treatment for Stage 4 Colorectal Cancer: Traditional Management with Surgery, Radiation, and Chemotherapy.
    Feria A; Times M
    Clin Colon Rectal Surg; 2024 Mar; 37(2):62-65. PubMed ID: 38322607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of circulating tumor DNA in a high-risk stage-IV rectal carcinoma patient with synchronous liver metastases after conversion surgery is correlated with pathologic complete response.
    Huang Y; Jia W; Wang L; Ou Q; Wu X; Xing B
    Ther Adv Gastrointest Endosc; 2021; 14():26317745211020279. PubMed ID: 34124665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and potential treatment of colorectal cancer metastasis to bone.
    Holladay L; Luu J; Balendra V; Kmetz K
    Cancer Treat Res Commun; 2023; 37():100763. PubMed ID: 37839182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for hepatic surgery in patients with liver metastatic breast cancer: review of literature.
    Bacalbaşa N; Alexandrescu ST; Popescu I
    Hepat Oncol; 2015 Apr; 2(2):159-170. PubMed ID: 30190995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary tumor resection for asymptomatic colorectal cancer with unresectable metastasis: the end of the dilemma.
    Biondo S; Frago R; Kreisler E
    Ann Oncol; 2024 Jul; ():. PubMed ID: 38969010
    [No Abstract]   [Full Text] [Related]  

  • 16. Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib: Three case reports.
    Tomonari T; Sato Y; Tanaka H; Tanaka T; Taniguchi T; Sogabe M; Okamoto K; Miyamoto H; Muguruma N; Saito Y; Imura S; Bando Y; Shimada M; Takayama T
    Medicine (Baltimore); 2020 Oct; 99(42):e22782. PubMed ID: 33080748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct gastric invasion from the liver metastasis of colorectal origin: A case report.
    Nam JY; Lee JW; Kim JH; Jung M; Park MI; Moon W; Kim SE; Jung K; Park SJ
    Medicine (Baltimore); 2024 Apr; 103(15):e37732. PubMed ID: 38608071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-center retrospective analysis of the efficacy and safety of a modified regimen of irinotecan plus S-1 (IRIS) with molecular targeting agents as second-line chemotherapy in Japanese patients with recurrent or nonresectable colorectal cancer.
    Higami S; Mukai M; Yokoyama D; Uda S; Abe R; Mamuro N; Kishima K; Hasegawa S; Tajima T; Nomura E; Makuuchi H
    J Gastrointest Oncol; 2023 Apr; 14(2):663-675. PubMed ID: 37201062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-course radiotherapy and chemotherapy for conversion surgery in patients with unresectable metastatic rectal cancer: a preliminary case series study.
    Jeon Y; Han KW; Lee SH; Sym SJ; Choi SJ; Ha SY; Baek JH
    Korean J Clin Oncol; 2021 Dec; 17(2):111-116. PubMed ID: 36945667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement.
    Aytaç E; Özer L; Baca B; Balık E; Kapran Y; Taşkın OC; Oyan Uluç B; Abacıoğlu MU; Gönenç M; Bölükbaşı Y; Çil BE; Baran B; Aygün C; Yıldız ME; Ünal K; Erkol B; Yaltı T; Özbek U; Attila T; Tözün N; Gürses B; Erdamar S; Er Ö; Beşe N; Bilge O; Ceyhan GO; Mandel NM; Selek U; Yakıcıer C; Kayserili Karabey H; Saruç M; Özben V; Esen E; Özoran E; Vardareli E; Güner L; Hamzaoğlu İ; Buğra D; Karahasanoğlu T; Group Tİ
    Turk J Gastroenterol; 2022 Aug; 33(8):627-663. PubMed ID: 35993526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.